vs
Side-by-side financial comparison of CPI Card Group Inc. (PMTS) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $153.1M, roughly 1.9× CPI Card Group Inc.). Bio-Techne runs the higher net margin — 12.8% vs 4.8%, a 8.0% gap on every dollar of revenue. On growth, CPI Card Group Inc. posted the faster year-over-year revenue change (22.3% vs -6.4%). Over the past eight quarters, CPI Card Group Inc.'s revenue compounded faster (16.9% CAGR vs 4.2%).
CPI Card Group Inc. is a leading provider of payment card production and associated solutions, including contactless and contact credit/debit cards, prepaid cards, and card personalization services. It primarily serves financial institutions, fintech firms, and retail brands across its core North American market.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
PMTS vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $153.1M | $295.9M |
| Net Profit | $7.3M | $38.0M |
| Gross Margin | 31.5% | 64.6% |
| Operating Margin | 12.0% | 18.4% |
| Net Margin | 4.8% | 12.8% |
| Revenue YoY | 22.3% | -6.4% |
| Net Profit YoY | 8.5% | 68.3% |
| EPS (diluted) | $0.62 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $153.1M | $295.9M | ||
| Q3 25 | $138.0M | — | ||
| Q2 25 | $129.8M | $317.0M | ||
| Q1 25 | $122.8M | $316.2M | ||
| Q4 24 | $125.1M | $297.0M | ||
| Q3 24 | $124.8M | $289.5M | ||
| Q2 24 | $118.8M | $306.1M | ||
| Q1 24 | $111.9M | $303.4M |
| Q4 25 | $7.3M | $38.0M | ||
| Q3 25 | $2.3M | — | ||
| Q2 25 | $518.0K | $-17.7M | ||
| Q1 25 | $4.8M | $22.6M | ||
| Q4 24 | $6.8M | $34.9M | ||
| Q3 24 | $1.3M | $33.6M | ||
| Q2 24 | $6.0M | $40.6M | ||
| Q1 24 | $5.5M | $49.1M |
| Q4 25 | 31.5% | 64.6% | ||
| Q3 25 | 29.7% | — | ||
| Q2 25 | 30.9% | 62.7% | ||
| Q1 25 | 33.2% | 67.9% | ||
| Q4 24 | 34.1% | 65.3% | ||
| Q3 24 | 35.8% | 63.2% | ||
| Q2 24 | 35.7% | 66.4% | ||
| Q1 24 | 37.1% | 67.4% |
| Q4 25 | 12.0% | 18.4% | ||
| Q3 25 | 9.4% | — | ||
| Q2 25 | 7.3% | -7.5% | ||
| Q1 25 | 11.5% | 12.2% | ||
| Q4 24 | 12.7% | 16.0% | ||
| Q3 24 | 14.3% | 13.8% | ||
| Q2 24 | 12.5% | 15.0% | ||
| Q1 24 | 12.6% | 22.1% |
| Q4 25 | 4.8% | 12.8% | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 0.4% | -5.6% | ||
| Q1 25 | 3.9% | 7.1% | ||
| Q4 24 | 5.4% | 11.7% | ||
| Q3 24 | 1.0% | 11.6% | ||
| Q2 24 | 5.1% | 13.3% | ||
| Q1 24 | 4.9% | 16.2% |
| Q4 25 | $0.62 | $0.24 | ||
| Q3 25 | $0.19 | — | ||
| Q2 25 | $0.04 | $-0.11 | ||
| Q1 25 | $0.40 | $0.14 | ||
| Q4 24 | $0.56 | $0.22 | ||
| Q3 24 | $0.11 | $0.21 | ||
| Q2 24 | $0.51 | $0.26 | ||
| Q1 24 | $0.46 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $21.7M | $172.9M |
| Total DebtLower is stronger | $286.7M | $260.0M |
| Stockholders' EquityBook value | $-17.3M | $2.0B |
| Total Assets | $403.2M | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $21.7M | $172.9M | ||
| Q3 25 | $16.0M | — | ||
| Q2 25 | $17.1M | $162.2M | ||
| Q1 25 | $31.5M | $140.7M | ||
| Q4 24 | $33.5M | $177.5M | ||
| Q3 24 | $14.7M | $187.5M | ||
| Q2 24 | $7.5M | $152.9M | ||
| Q1 24 | $17.1M | $145.3M |
| Q4 25 | $286.7M | $260.0M | ||
| Q3 25 | $308.4M | — | ||
| Q2 25 | $310.9M | $346.0M | ||
| Q1 25 | $280.7M | $330.0M | ||
| Q4 24 | $280.4M | $300.0M | ||
| Q3 24 | $280.2M | $300.0M | ||
| Q2 24 | $269.7M | $319.0M | ||
| Q1 24 | $265.3M | $389.0M |
| Q4 25 | $-17.3M | $2.0B | ||
| Q3 25 | $-25.7M | — | ||
| Q2 25 | $-29.0M | $1.9B | ||
| Q1 25 | $-29.7M | $2.0B | ||
| Q4 24 | $-35.6M | $2.1B | ||
| Q3 24 | $-42.8M | $2.1B | ||
| Q2 24 | $-44.6M | $2.1B | ||
| Q1 24 | $-48.5M | $2.0B |
| Q4 25 | $403.2M | $2.5B | ||
| Q3 25 | $407.1M | — | ||
| Q2 25 | $399.8M | $2.6B | ||
| Q1 25 | $351.9M | $2.6B | ||
| Q4 24 | $349.7M | $2.7B | ||
| Q3 24 | $342.3M | $2.7B | ||
| Q2 24 | $321.4M | $2.7B | ||
| Q1 24 | $319.8M | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $39.6M | — |
| Free Cash FlowOCF − Capex | $35.2M | — |
| FCF MarginFCF / Revenue | 23.0% | — |
| Capex IntensityCapex / Revenue | 2.9% | — |
| Cash ConversionOCF / Net Profit | 5.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | $41.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $39.6M | — | ||
| Q3 25 | $10.0M | — | ||
| Q2 25 | $4.3M | $98.2M | ||
| Q1 25 | $5.6M | $41.1M | ||
| Q4 24 | $26.7M | $84.3M | ||
| Q3 24 | $12.5M | $63.9M | ||
| Q2 24 | $-4.8M | $75.5M | ||
| Q1 24 | $8.9M | $81.0M |
| Q4 25 | $35.2M | — | ||
| Q3 25 | $5.3M | — | ||
| Q2 25 | $533.0K | $93.3M | ||
| Q1 25 | $292.0K | $31.0M | ||
| Q4 24 | $21.6M | $77.5M | ||
| Q3 24 | $11.1M | $54.7M | ||
| Q2 24 | $-6.0M | $57.5M | ||
| Q1 24 | $7.4M | $64.5M |
| Q4 25 | 23.0% | — | ||
| Q3 25 | 3.8% | — | ||
| Q2 25 | 0.4% | 29.4% | ||
| Q1 25 | 0.2% | 9.8% | ||
| Q4 24 | 17.3% | 26.1% | ||
| Q3 24 | 8.9% | 18.9% | ||
| Q2 24 | -5.0% | 18.8% | ||
| Q1 24 | 6.6% | 21.3% |
| Q4 25 | 2.9% | — | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 2.9% | 1.5% | ||
| Q1 25 | 4.3% | 3.2% | ||
| Q4 24 | 4.0% | 2.3% | ||
| Q3 24 | 1.2% | 3.2% | ||
| Q2 24 | 1.0% | 5.9% | ||
| Q1 24 | 1.3% | 5.4% |
| Q4 25 | 5.39× | — | ||
| Q3 25 | 4.32× | — | ||
| Q2 25 | 8.39× | — | ||
| Q1 25 | 1.17× | 1.82× | ||
| Q4 24 | 3.94× | 2.42× | ||
| Q3 24 | 9.70× | 1.90× | ||
| Q2 24 | -0.79× | 1.86× | ||
| Q1 24 | 1.63× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PMTS
| US Debit And Credit | $128.9M | 84% |
| US Prepaid Debit | $24.4M | 16% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
